MTOR and hepatocellular carcinoma: In another study, SNAT1 regulated the development of hepatocellular carcinoma by modulating phosphatidylinositol 3-kinase (PI3K)/protein kinase B (AKT)/mammalian target of rapamycin (mTOR) signaling via glutamine-mediated energy metabolism [21].